5-(4-(4-methoxyphenoxy)benzylidene)-3-(4-(3-(4-methylpiperazin-1-yl)propoxy)phenyl)-2-thioxothiazolidin-4-one

ID: ALA3765189

Chembl Id: CHEMBL3765189

PubChem CID: 71656007

Max Phase: Preclinical

Molecular Formula: C31H33N3O4S2

Molecular Weight: 575.76

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(Oc2ccc(/C=C3\SC(=S)N(c4ccc(OCCCN5CCN(C)CC5)cc4)C3=O)cc2)cc1

Standard InChI:  InChI=1S/C31H33N3O4S2/c1-32-17-19-33(20-18-32)16-3-21-37-26-10-6-24(7-11-26)34-30(35)29(40-31(34)39)22-23-4-8-27(9-5-23)38-28-14-12-25(36-2)13-15-28/h4-15,22H,3,16-21H2,1-2H3/b29-22-

Standard InChI Key:  SHCXHKHACONKEG-IADYIPOJSA-N

Associated Targets(Human)

IKBKB Tchem Inhibitor of nuclear factor kappa B kinase beta subunit (5554 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Ikbkb Inhibitor of nuclear factor kappa-B kinase subunit beta (81 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (10718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 575.76Molecular Weight (Monoisotopic): 575.1912AlogP: 5.91#Rotatable Bonds: 10
Polar Surface Area: 54.48Molecular Species: NEUTRALHBA: 8HBD: 0
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 0#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 8.11CX LogP: 5.73CX LogD: 4.95
Aromatic Rings: 3Heavy Atoms: 40QED Weighted: 0.17Np Likeness Score: -1.38

References

1. Kim D, Kim YG, Seo JH, Shin KJ..  (2016)  Identification and characterization of potent, selective and metabolically stable IKKβ inhibitor.,  26  (4): [PMID:26826731] [10.1016/j.bmcl.2016.01.065]

Source